ClinicalTrials.Veeva

Menu

Chinese Herb Nephropathy Epidemiology and Association With CYP2D6, CYP2C19, PXR, or MDR1 Polymorphism

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Kidney Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT01503645
95D010
9461701139

Details and patient eligibility

About

  1. Chinese herb nephropathy (CHN), a kind of kidney failure caused by Chinese herbs, may be related to the a component called aristolochic acid (AA).
  2. AA may form AA-DNA adducts and accumulate in the kidney and ureter and cause kidney failure and/or cancer
  3. Different enzymes have been reported to detoxify plant alkaloids or other components. Genes that regulate the production of these metabolic enzymes may affect the chance of CHN.
  4. By comparing the differences in the polymorphisms of these genes between patient with CHN and control, we may find the changes that play a significant genetic factors for CHN.

Enrollment

200 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patient with suspected Chinese herb nephropathy, and their family Control group match for sex age and geographic area (with or without herabla use)

Trial contacts and locations

2

Loading...

Central trial contact

Fe-Lin L Wu, Ph.D.; Kwan-Dun Wu, MD, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems